Anticorps Recombinant de lapin anti-ENPP3/CD203c

ENPP3/CD203c Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC

Conjugaison

Non conjugué

CloneNo.

242965D11

N° de cat : 98490-2-RR

Synonymes

ENPP3, B10, CD203c, E NPP 3, PD IBETA



Applications testées

Résultats positifs en cytométrieCMSP humaines,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98490-2-RR cible ENPP3/CD203c dans les applications de FC et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène ENPP3/CD203c Protéine recombinante Eg2369
Nom complet ectonucleotide pyrophosphatase/phosphodiesterase 3
Masse moléculaire calculée 875 aa, 100 kDa
Numéro d’acquisition GenBankBC146579
Symbole du gène ENPP3
Identification du gène (NCBI) 5169
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

ENPP3, also known as CD203c, is part of ectonucleotide pyrophosphatases/phosphodiesterase (ENPP) family and plays a role in various physiological processes. Increased levels of ENPP3 have been observed in conditions, such as clear cell renal cell carcinoma, bile duct carcinoma, and colorectal cancer, positioning ENPP3 as a potential tumor marker (PMID: 38749434). Mice harboring a point mutant of ENPP3 that specifically abolishes its cGAMP hydrolase activity are more resistant to both primary tumor growth and metastasis in certain cancers (PMID: 38149831).

Protocole

Product Specific Protocols
FC protocol for ENPP3/CD203c antibody 98490-2-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}